Skip to main content

Clinical Trials Using Recombinant Human Papillomavirus Nonavalent Vaccine

Review the clinical trials studying recombinant human papillomavirus nonavalent vaccine on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-3 of 3

HPV L1 Vaccine in Combination with Imiquimod and Metformin for the Treatment of Locally Advanced and Metastatic Cervical, Vaginal and Vulvar Cancers Undergoing Chemoradiation
Status: Active
Location: 2 locations
Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.
Status: Active
Location: See ClinicalTrials.gov
Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Status: Active
Location: University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin